Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia

Haematologica

Volumn 92, Issue 12, 2007, Pages 1687-1690

  Osugi, Yuko ^a   Yagasaki, Hiroshi ^b   Sako, Masahiro ^a   Kosaka, Yoshiyuki ^c   Taga, Takashi ^d   Ito, Tsuyoshi ^e   Yamamoto, Masuji ^f   Ohara, Akira ^g   Sato, Takeyuki ^h   Mimaya, Junichi ⁱ   Tsukimoto, Ichiro ^g   Kojima, Seiji ^b  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^e Toyohashi City Hospital Toyohashi   (Japan)

^f HYOGO COLLEGE OF MEDICINE   (Japan)

^g TOHO UNIVERSITY   (Japan)

^h CHIBA UNIVERSITY   (Japan)

ⁱ SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

Author keywords

Antithymocyte globulin; Children; Cyclosporine; Hepatitis associated aplastic anemia

Indexed keywords

CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; THYMOCYTE ANTIBODY;

APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG RESPONSE; FEMALE; HEPATITIS; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TOXICITY; MALE; OUTCOME ASSESSMENT; SIBLING; SURVIVAL RATE; TREATMENT RESPONSE;

ADOLESCENT; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 37049022811     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11359     Document Type: Article

References (18)

1. Lorenz E, Quaiser K. Panmyelopathy following epidemic hepatitis. Wien Med Wochenschr 1955;105:19-22.
2. Hagler L, Pastore RA, Bergin JJ, Wrensch MR. Aplastic anemia following viral hepatitis: report of two fatal cases and literature review. Medicine (Baltimore) 1975;54:139-64.
3. Kojima S, Matsuyama K, Kodera Y, Okada J. Circulating activated suppressor T lymphocytes in hepatitis-associated aplastic anaemia. Br J Haematol 1989;71:147-51.
4. Lu J, Basu A, Melenhorst JJ, Young NS, Brown KE. Analysis of T-cell repertoire in hepatitis-associated aplastic anemia. Blood 2004;103:4588-93.
5. Brown KE, Tisdale J, Barrett AJ, Dunbar CE, Young NS. Hepatitis-associated aplastic anemia. N Engl J Med 1997;336:1059-64.
6. Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopechy KJ, Pappeport JM, et al. A prospective study of androgen and bone marrow transplantation for treatment of severe aplastic anemia. Blood 1979;53:504-14.
7. Kojima S, Hibi S, Kosaka Y, Yamamoto M, Tsuchida M, Mugishima H, et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 2000;96:2049-54.
8. Sano K, Hibi S, Sato T, Ayukawa H, Kinoshita A, Kigasawa T, et al. Prospective multicenter trial comparing repeated immunosuppressive therapy (IST) versus stem cell transplantation (SCT) as a second line treatment for IST-resistant aplastic anemia (AA) children. Blood 2000; 96 Suppl 1:6a[abstract].
9. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
10. Mary JY, Baumelou E, Guiguet M. Epidemiology of aplastic anemia in France: a prospective multicentric study. Blood 1990;75:1646-53.
11. Young NS, Issaragrisil S, Chieh CW, Takaku F. Aplastic anaemia in the Orient. Br J Haematol 1986;62:1-6
12. Savage WJ, DeRusso PA, Resar LM, Chen AR, Higman MA, Loeb DM, et al. Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide. Pediatr Blood Cancer 2007, on line (DOI 10.1002/pbc.21143)
13. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med 1991;324:1297-304.
14. Rosenfeld SJ, Kimball J, Vining D, Young NS. Intensive immunosuppression widi antidiymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 1995;85:3058-65.
15. Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A, et al. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood 1995;85:1348-53.
16. van Hattum J, van Oudenaren A, Schalm SW, Visser JW, Benner R. T-lymphocyte subpopulations in patients widi various courses after hepatitis B virus infection. Scand J Gastroenterol 1984;19:497-501.
17. + ratio of liver-derived lymphocytes correlates with viral replication in chronic hepatitis B. Clin Exp Immunol 1994; 97:403-10.
18. Ono K, Tanaka Y, Kusano F, Kakinuma S, Ishidate K, Watanabe M, et al. Fas-ligand and perforin expression in infiltrating cytotoxic T lymphocytes in the liver of chronic hepatitis C. Hepatol Res 2002; 23:153-62.